Loki Therapeutics Broadcasts Publication in Science Translational Medication Demonstrating Potential of AWAKE-LM-TT as a Remedy for Pancreatic Most cancers
Novel strategy developed at Albert Einstein School of Medication leverages childhood tetanus vaccination to direct immune system in opposition to pancreatic tumors LONG ISLAND CITY, N.Y., March 28, 2022 /PRNewswire/ — Loki Therapeutics, an organization growing next-generation therapeutics that leverage vaccination recall antigens to reinforce longevity and deal with immune-system associated illnesses, together with most…